Andres Cervantes (A Cervantes, Andrés Cervantes)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 48

Top Venues

Cancers

Clinical cancer research : an official journal of the American Association for Cancer Research

ESMO open

Journal of experimental & clinical cancer research : CR

University of Valencia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Valencia Feb 12 1992

Spain

Professor of Medicine :: Medical Oncoloy

Publications

Komal L Jhaveri, Melissa K Accordino, Philippe L Bedard, Andres Cervantes, Valentina Gambardella, Erika Paige Hamilton, Antoine Italiano, Kevin M Kalinsky, Ian E Krop, Mafalda Oliveira, Peter Schmid, Cristina Saura, Nicholas C Turner, Andrea Varga, Sravanthi Cheeti, Stephanie Hilz, Katherine E Hutchinson, Yanling Jin, Stephanie Royer-Joo, Ubong Peters, Noopur Shankar, Jennifer L Schutzman, Dejan Juric
Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA -Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Petros D Grivas, Elena Garralda, Funda Meric-Bernstam, Ingo K Mellinghoff, Lipika Goyal, James J Harding, Elizabeth C Dees, Rastislav Bahleda, Nilofer S Azad, Asha Karippot, Razelle Kurzrock, Josep Tabernero, Juha Kononen, Matthew Chau Hsien Ng, Rutika Mehta, Nataliya V Uboha, Frédéric Bigot, Valentina Boni, Samantha E Bowyer, Valeriy Breder, Andres Cervantes, Nancy Chan, James M Cleary, Mallika Dhawan, Rikke Helene Løvendahl Eefsen, James Ewing, Donna M Graham, Tormod Kyrre Guren, Jin Won Kim, Krassimir Koynov, Do Youn Oh, Rebecca A Redman, Chia-Jui Yen, David B Spetzler, Marie-Claude Roubaudi-Fraschini, Valérie Nicolas, Rafik Ait-Sarkouh, Claudio Zanna, Abdallah Ennaji, Anna Pokorska-Bocci, Keith T Flaherty
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Federica Papaccio, Blanca García-Mico, Francisco Gimeno-Valiente, Manuel Cabeza-Segura, Valentina Gambardella, María Fernanda Gutiérrez-Bravo, Clara Alfaro-Cervelló, Carolina Martinez-Ciarpaglini, Pilar Rentero-Garrido, Sheila Zúñiga-Trejos, Juan Antonio Carbonell-Asins, Tania Fleitas, Susana Roselló, Marisol Huerta, Manuel M Sánchez Del Pino, Luís Sabater, Desamparados Roda, Noelia Tarazona, Andres Cervantes, Josefa Castillo
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction". Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Federica Papaccio, Blanca García-Mico, Francisco Gimeno-Valiente, Manuel Cabeza-Segura, Valentina Gambardella, María Fernanda Gutiérrez-Bravo, Clara Alfaro-Cervelló, Carolina Martinez-Ciarpaglini, Pilar Rentero-Garrido, Sheila Zúñiga-Trejos, Juan Antonio Carbonell-Asins, Tania Fleitas, Susana Roselló, Marisol Huerta, Manuel M Sánchez Del Pino, Luís Sabater, Desamparados Roda, Noelia Tarazona, Andres Cervantes, Josefa Castillo
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction". Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Jayesh Desai, Guzman Alonso, Se Hyun Kim, Andres Cervantes, Thomas Benjamin Karasic, Laura Medina, Einat Shacham-Shmueli, Rasha Cosman, Alejandro Falcón Gonzalez, Eelke Gort, Tormod Kyrre Guren, Erminia Massarelli, Wilson H Miller, Luis Paz-Ares, Hans Prenen, Alessio Amatu, Chiara Cremolini, Tae Won Kim, Victor Moreno, Sai-Hong Ignatius Ou, Alessandro Passardi, Adrian Sacher, Armando Santoro, Rafal Stec, Susanna Ulahannan, Kathryn C Arbour, Patricia M LoRusso, Jia Luo, Manish R Patel, Yoonha Choi, Zhen Shi, Sandhya Mandlekar, Mark T Lin, Stephanie Royer-Joo, Julie Chang, Tomi Jun, Neekesh V Dharia, Jennifer L Schutzman, null null, Sae-Won Han
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial. Nature medicine (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
J Sancho-Muriel, F Giner, Hanna Cholewa, A Garcia-Granero, S Roselló, B Flor-Lorente, Andres Cervantes, E Garcia-Granero, Matteo Frasson
The percentage of mesorectal infiltration as a prognostic factor after curative surgery for pT3 rectal cancer. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2023)
Federica Papaccio, Blanca García-Mico, Francisco Gimeno-Valiente, Manuel Cabeza-Segura, Valentina Gambardella, María Fernanda Gutiérrez-Bravo, Clara Alfaro-Cervelló, Carolina Martinez-Ciarpaglini, Pilar Rentero-Garrido, Sheila Zúñiga-Trejos, Juan Antonio Carbonell-Asins, Tania Fleitas, Susana Roselló, Marisol Huerta, Manuel M Sánchez Del Pino, Luís Sabater, Desamparados Roda, Noelia Tarazona, Andres Cervantes, Josefa Castillo
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction". Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Michael L Friedlander, Linda Mileshkin, Janine Lombard, Sophia Frentzas, Bo Gao, Michelle Wilson, Tarek Meniawy, Sally Baron-Hay, Karen Briscoe, Nicole McCarthy, Christos Fountzilas, Andres Cervantes, Ruimin Ge, John Wu, Alexander Spira
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial. British journal of cancer (2023)
Federica Papaccio, Blanca García-Mico, Francisco Gimeno-Valiente, Manuel Cabeza-Segura, Valentina Gambardella, María Fernanda Gutiérrez-Bravo, Clara Alfaro-Cervelló, Carolina Martinez-Ciarpaglini, Pilar Rentero-Garrido, Sheila Zúñiga-Trejos, Juan Antonio Carbonell-Asins, Tania Fleitas, Susana Roselló, Marisol Huerta, Manuel M Sánchez Del Pino, Luís Sabater, Desamparados Roda, Noelia Tarazona, Andres Cervantes, Josefa Castillo
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction". Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Federica Papaccio, Blanca García-Mico, Francisco Gimeno-Valiente, Manuel Cabeza-Segura, Valentina Gambardella, María Fernanda Gutiérrez-Bravo, Clara Alfaro-Cervelló, Carolina Martinez-Ciarpaglini, Pilar Rentero-Garrido, Sheila Zúñiga-Trejos, Juan Antonio Carbonell-Asins, Tania Fleitas, Susana Roselló, Marisol Huerta, Manuel M Sánchez Del Pino, Luís Sabater, Desamparados Roda, Noelia Tarazona, Andres Cervantes, Josefa Castillo
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction". Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Jorge Sancho-Muriel, Francisco Giner, Hanna Cholewa, Álvaro Garcia-Granero, Susana Roselló, Blas Flor-Lorente, Andres Cervantes, Eduardo Garcia-Granero, Matteo Frasson
The percentage of mesorectal infiltration as a prognostic factor after curative surgery for pT3 rectal cancer. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2023)
Benedito Arruda Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, Anwaar Saeed, Howard Safran, Wen Wee Ma, Andrew L Coveler, Steven Francis Powell, Bruno R Bastos, Elizabeth J Davis, Vaibhav Sahai, William Mikrut, James Longstreth, Sheri Smith, Taylor M Weiskittel, Hu Li, Brittany A Borden, Robert Donald Harvey, Solmaz Sahebjam, Andres Cervantes, Austin Koukol, Andrew P Mazar, Neeltje Steeghs, Razelle Kurzrock, Francis J Giles, Pamela N Munster
Phase 1 study of Elraglusib (9-ING-41), a glycogen synthase kinase-3b inhibitor, as monotherapy or combined with chemotherapy in patients with advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Marta J Llorca-Cardenosa, Lauren I Aronson, Dragomir B Krastev, Jadwiga Nieminuszczy, John Alexander, Feifei Song, Malgorzata Dylewska, Ronan Broderick, Rachel Brough, Astrid Zimmermann, Frank T Zenke, Bora Gurel, Ruth Riisnaes, Ana Ferreira, Theodoros I Roumeliotis, Jyoti Sharma Choudhary, Stephen J Pettitt, Johann S de Bono, Andres Cervantes, Syed Haider, Wojciech Niedzwiedz, Christopher J Lord, Irene Y Chong
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance. Cancer research 82 (21) (2022)
Paula Montero, Martín Pérez-Leal, Jose Alejandro Pérez-Fidalgo, Celia Sanz, Cristina Estornut, Inés Roger, Javier Milara, Andres Cervantes, Julio Cortijo
Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients. Cancers 14 (5) (2022)
Aleix Prat, Luis G Paz-Ares, Manel Juan, Enriqueta Felip Font, Elena Garralda, Blanca Gonzalez-Farre, Ana M Arance, Juan Martín-Liberal, Joaquín Gavilá, Ana López-González, Juan Miguel Cejalvo, Yann Izarzugaza, Kepa Amillano, Javier García Corbacho, Cristina Saura, Fabricio Racca, Cinta Hierro, Esther Sanfeliu, Xavier Gonzalez, Jordi Canes, Guillermo Villacampa, Fernando Salvador, Tomás Pascual, Ricard Mesía, Andres Cervantes, Josep Tabernero
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA. Future oncology (London, England) (2022)
Marta Albanell, Sara S Oltra, Marta Orts-Arroyo, Maider Ibarrola-Villava, Fany Carrasco, Elena Jiménez-Martí, Andres Cervantes, Isabel Castro, Jose Martínez-Lillo, Gloria Ribas
RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines. Cancers 15 (1) (2022)
Marta Albanell, Sara S Oltra, Marta Orts-Arroyo, Maider Ibarrola-Villava, Fany Carrasco, Elena Jiménez-Martí, Andres Cervantes, Isabel Castro, Jose Martínez-Lillo, Gloria Ribas
RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines. Cancers 15 (1) (2022)
Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, Michael J Pishvaian, Yung-Jue Bang, Michael S Gordon, Ahmad Awada, D Ross Camidge, F Stephen Hodi, Grant A McArthur, Wilson H Miller, Andres Cervantes, Laura Q M Chow, Alexander M Lesokhin, Annemie Rutten, Mario Sznol, Deepali Rishipathak, Shang-Chiung Chen, Eric G Stefanich, Tony Pourmohamad, Maria Anderson, Jeong Kim, Mahrukh Huseni, Ina Rhee, Lillian L Siu
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Marta Albanell, Sara S Oltra, Marta Orts-Arroyo, Maider Ibarrola-Villava, Fany Carrasco, Elena Jiménez-Martí, Andres Cervantes, Isabel Castro, Jose Martínez-Lillo, Gloria Ribas
RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines. Cancers 15 (1) (2022)
Manuel Cabeza-Segura, Valentina Gambardella, Francisco Gimeno-Valiente, Juan Antonio Carbonell-Asins, Lorena Alarcón-Molero, Arturo González-Vilanova, Sheila Zuñiga-Trejos, Pilar Rentero-Garrido, Rosana Villagrasa, Mireia Gil, Ana Durá, Paula Richart, Noelia Alonso, Marisol Huerta, Susana Roselló, Desamparados Roda, Noelia Tarazona, Carolina Martínez-Ciarpaglini, Josefa Castillo, Andres Cervantes, Tania C Fleitas
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma. British journal of cancer 127 (12) (2022)
Federica Papaccio, Manuel Cabeza-Segura, Blanca Garcia-Micò, Noelia Tarazona, Desamparados Roda, Josefa Castillo, Andres Cervantes
Will Organoids Fill the Gap towards Functional Precision Medicine? Journal of personalized medicine 12 (11) (2022)
Valentina Gambardella, Pasquale Lombardi, Juan Antonio Carbonell-Asins, Noelia Tarazona, Juan Miguel Cejalvo, Inés González-Barrallo, Jorge Martín-Arana, Roberto Tébar-Martínez, Alba Viala, Gema Bruixola, Cristina Hernando, Inma Blasco, Federica Papaccio, Carolina Martínez-Ciarpaglini, Clara Alfaro-Cervelló, Enrique Seda-García, Sebastián Blesa, Isabel Chirivella, Josefa Castillo, José Vicente Montón-Bueno, Susana Roselló, Marisol Huerta, Alejandro Pérez-Fidalgo, Paloma Martín-Martorell, Amelia Insa-Mollá, Tania Fleitas, Pilar Rentero-Garrido, Sheila Zúñiga-Trejos, Andres Cervantes, Desamparados Roda
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study. British journal of cancer 125 (9) (2021)
Marisol Huerta, Susana Roselló, Luis Sabater, Ana Ferrer, Noelia Tarazona, Desamparados Roda, Valentina Gambardella, Clara Alfaro-Cervello, Marina Garcés-Albir, Andres Cervantes, Maider Ibarrola-Villava
Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review. Cancers 13 (5) (2021)
Timothy Anthony Yap, Maria Vieito, Capucine Baldini, Juan Manuel Sepúlveda-Sánchez, Shunsuke Kondo, Matteo Simonelli, Rasha Cosman, Andre van der Westhuizen, Victoria Atkinson, Antoine F Carpentier, Mario Löhr, Rebecca Redman, Warren Mason, Andres Cervantes, Emilie Le Rhun, Sebastian Ochsenreither, Louise Warren, Yumin Zhao, Sophie Callies, Shawn T Estrem, Michael Man, Leena Gandhi, Emin Avsar, Davide Melisi
First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Francisco Gimeno-Valiente, Ángela L Riffo-Campos, Luis Torres, Noelia Tarazona, Valentina Gambardella, Andres Cervantes, Gerardo López-Rodas, Luis Franco, Josefa Castillo
Epigenetic Mechanisms Are Involved in the Oncogenic Properties of ZNF518B in Colorectal Cancer. Cancers 13 (6) (2021)
Tenna Vesterman Henriksen, Noelia Tarazona, Amanda Frydendahl, Thomas Reinert, Francisco Gimeno-Valiente, Juan Antonio Carbonell-Asins, Shruti Sharma, Derrick Renner, Dina Hafez, Desamparados Roda, Marisol Huerta, Susana Roselló, Anders Husted Madsen, Uffe Schou Løve, Per Vadgaard Andersen, Ole Thorlacius-Ussing, Lene Hjerrild Iversen, Kåre Andersson Gotschalck, Himanshu Sethi, Alexey Aleshin, Andres Cervantes, Claus Lindbjerg Andersen
Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Federica Papaccio, Susana Roselló, Marisol Huerta, Valentina Gambardella, Noelia Tarazona, Tania Fleitas, Desamparados Roda, Andres Cervantes
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer. Cancers 12 (12) (2020)
Valentina Gambardella, Noelia Tarazona, Juan Miguel Cejalvo, Pasquale Lombardi, Marisol Huerta, Susana Roselló, Tania Fleitas, Desamparados Roda, Andres Cervantes
Personalized Medicine: Recent Progress in Cancer Therapy. Cancers 12 (4) (2020)
Valentina Gambardella, Tania Fleitas, Noelia Tarazona, Federica Papaccio, Marisol Huerta, Susana Roselló, Francisco Gimeno-Valiente, Desamparados Roda, Andres Cervantes
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress. Journal of clinical medicine 9 (9) (2020)
F Gimeno-Valiente, Á L Riffo-Campos, G Ayala, N Tarazona, V Gambardella, F M Rodríguez, Marisol Huerta, C Martínez-Ciarpaglini, J Montón-Bueno, S Roselló, D Roda, Andres Cervantes, Luis Franco, G López-Rodas, J Castillo
EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness. Scientific reports 10 (1) (2020)
Francisco Gimeno-Valiente, Ángela L Riffo-Campos, Azahara Vallet-Sánchez, Sofía Siscar-Lewin, Valentina Gambardella, Noelia Tarazona, Andres Cervantes, Luis Franco, Josefa Castillo, Gerardo López-Rodas
ZNF518B gene up-regulation promotes dissemination of tumour cells and is governed by epigenetic mechanisms in colorectal cancer. Scientific reports 9 (1) (2019)
Chanthirika Ragulan, Katherine Eason, Elisa Fontana, Gift Nyamundanda, Noelia Tarazona, Yatish Patil, Pawan Poudel, Rita T Lawlor, Maguy Del Rio, Si-Lin Koo, Wah-Siew Tan, Francesco Sclafani, Ruwaida Begum, Larissa S Teixeira Mendes, Pierre Martineau, Aldo Scarpa, Andres Cervantes, Iain Beehuat Tan, David Cunningham, Anguraj Sadanandam
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes. Scientific reports 9 (1) (2019)
Juan-Miguel Cejalvo, Wolfgang Jacob, Tania Fleitas Kanonnikoff, Enriqueta Felip, Alejandro Navarro Mendivil, Maria Martinez-García, Alvaro Taus Garcia, Natasha Leighl, Ulrik Lassen, Morten Mau-Soerensen, Celine Adessi, Francesca Michielin, Ian James, Maurizio Ceppi, Max Hasmann, Martin Weisser, Andres Cervantes
A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer. ESMO open 4 (4) (2019)
Lillian M Smyth, Sarina A Piha-Paul, Helen H Won, Alison M Schram, Cristina Saura, Sherene Loi, Janice Lu, Geoffrey I Shapiro, Dejan Juric, Ingrid A Mayer, Carlos L Arteaga, Macarena I de la Fuente, Adam M Brufksy, Iben Spanggaard, Morten Mau Sorensen, Monica Arnedos, Victor Moreno, Valentina Boni, Joohyuk Sohn, Lee S Schwartzberg, Xavier Gonzalez, Andres Cervantes, François-Clement Bidard, Alexander N Gorelick, Richard B Lanman, Rebecca J Nagy, Gary A Ulaner, Sarat Chandarlapaty, Komal Jhaveri, Elena I Gavrila, Catherine Zimel, S Duygu Selcuklu, Myra Melcer, Aliaksandra Samoila, Yanyan Cai, Maurizio Scaltriti, Grace Mann, Feng Xu, Lisa D Eli, Melanie Dujka, Alshad S Lalani, Richard Bryce, José Baselga, Barry S Taylor, David B Solit, Funda Meric-Bernstam, David M Hyman
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer. Cancer discovery 10 (2) (2019)
Noelia Tarazona, Valentina Gambardella, Paolma Martín-Martorell, Andres Cervantes
In the literature: October 2019. ESMO open 4 (6) (2019)
Florian Lordick, Radka Obermannova, Doris Vola, Jean-Yves Douillard, Keith Mcgregor, Eric Van Cutsem, Josep Tabernero, Fortunato Ciardiello, Andres Cervantes
Educational needs in gastrointestinal cancer: a consensus position paper from the ESMO Gastrointestinal Cancer Faculty. ESMO open 4 (3) (2019)
A Borrero-Palacios, A Cebrián, M T Gómez Del Pulgar, R García-Carbonero, P Garcia-Alfonso, E Aranda, E Elez, R López-López, Andres Cervantes, M Valladares, C Nadal, J M Viéitez, Carmen Guillén-Ponce, J Rodríguez, I Hernández, J L García, R Vega-Bravo, A Puime-Otin, J Martínez-Useros, L Del Puerto-Nevado, R Rincón, M Rodríguez-Remírez, F Rojo, J García-Foncillas
Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer. Scientific reports 9 (1) (2019)
Angela Lamarca, Valentina Gambardella, Juan-Miguel Cejalvo, Tania Fleitas-Kanonnikoff, Andres Cervantes
In the literature: June 2019. ESMO open 4 (3) (2019)
Valentina Gambardella, Gema Bruixola, Federica Papaccio, Juan-Miguel Cejalvo, Andres Cervantes
In the literature: August 2018. ESMO open 4 (4) (2019)
A Borrero-Palacios, A Cebrián, M T Gómez Del Pulgar, R García-Carbonero, P Garcia-Alfonso, E Aranda, E Elez, R López-López, Andres Cervantes, M Valladares, C Nadal, J M Viéitez, Carmen Guillén-Ponce, J Rodríguez, I Hernández, J L García, R Vega-Bravo, A Puime-Otin, J Martínez-Useros, L Del Puerto-Nevado, R Rincón, M Rodríguez-Remírez, F Rojo, J García-Foncillas
Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer. Scientific reports 9 (1) (2019)
Claudia Cardone, Erika Martinelli, Teresa Troiani, Vincenzo Sforza, Antonio Avallone, Anna Nappi, Vincenzo Montesarchio, Francesca Andreozzi, Maria Biglietto, Filomena Calabrese, Roberto Bordonaro, Stefano Cordio, Giacomo Bregni, Antonio Febbraro, Rocio Garcia-Carbonero, Jaime Feliu, Andres Cervantes, Fortunato Ciardiello
Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer. ESMO open 4 (4) (2019)
Kyung Hae Jung, Patricia LoRusso, Howard Burris, Michael Gordon, Yung-Jue Bang, Matthew D Hellmann, Andres Cervantes, Maria Ochoa de Olza, Aurelien Marabelle, F Stephen Hodi, Myung-Ju Ahn, Leisha A Emens, Fabrice Barlesi, Omid Hamid, Emiliano Calvo, David McDermott, Hatem Soliman, Ina Rhee, Ray Lin, Tony Pourmohamad, Julia Suchomel, Amy Tsuhako, Kari Morrissey, Sami Mahrus, Roland Morley, Andrea Pirzkall, S Lindsey Davis
Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (11) (2019)
Valentina Gambardella, Francisco Gimeno-Valiente, Noelia Tarazona, Carolina Martinez-Ciarpaglini, Desamparados Roda, Tania Fleitas, Pablo Tolosa, Juan Miguel Cejalvo, Marisol Huerta, Susana Roselló, Josefa Castillo, Andres Cervantes
NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (5) (2018)

Andres Cervantes.css-eqlu8i{font-size:small;padding-left:4px;} (A Cervantes, Andrés Cervantes)

Publication Activity (10 Years)

Top Topics

Top Venues

Andres Cervantes (A Cervantes, Andrés Cervantes)